Probiotic Bacillus licheniformis ZW3 Alleviates DSS-Induced Colitis and Enhances Gut Homeostasis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25010561 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dan Jia und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Inst…. Hauptthemen laut MEDLINE: Bacillus licheniformis, Bacillus, Colitis, Probiotics. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Agricultural Sciences, Ministry of Agriculture of the PRC, National Beef and Cattle Industry Technology System.
Abstract (Originalsprache)
Despite Bacillus species having been extensively utilized in the food industry and biocontrol as part of probiotic preparations, limited knowledge exists regarding their impact on intestinal disorders. In this study, we investigated the effect of Bacillus licheniformis ZW3 (ZW3), a potential probiotic isolated from camel feces, on dextran sulfate sodium (DSS)-induced colitis. The results showed ZW3 partially mitigated body weight loss, disease activity index (DAI), colon shortening, and suppressed immune response in colitis mice, as evidenced by the reduction in the levels of the inflammatory markers IL-1β, TNF-α, and IL-6 (p < 0.05). ZW3 was found to ameliorate DSS-induced dysfunction of the colonic barrier by enhancing mucin 2 (MUC2), zonula occluden-1 (ZO-1), and occludin. Furthermore, enriched beneficial bacteria Lachnospiraceae_NK4A136_group and decreased harmful bacteria Escherichia-Shigella revealed that ZW3 improved the imbalanced gut microbiota. Abnormally elevated uric acid levels in colitis were further normalized upon ZW3 supplementation. Overall, this study emphasized the protective effects of ZW3 in colitis mice as well as some potential applications in the management of inflammation-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.
- College of Coastal Agricultural Sciences, Department of Veterinary Medicine, Guangdong Ocean University, Zhanjiang 524088, China.
ORCID-Profile: Yanan Guo, Jinming Wang
Förderung
- Chinese Academy of Agricultural Sciences
- Ministry of Agriculture of the PRC
- National Beef and Cattle Industry Technology System
- program for scientific research start-up funds of Guangdong Ocean University
- Datong County Science and Technology Planning Project
- Key Research and Development Program of Ningxia Hui Autonomous Region
- Probiotics Program
- Science Fund for Creative Research Groups of Gansu Province
Zitieren
APA
Jia, D., Li, Y., Wang, Y., Guo, Y., Liu, J., Zhao, S., Wang, J., Guan, G., Luo, J., Yin, H., Tang, L., & Li, Y. (2024). Probiotic Bacillus licheniformis ZW3 Alleviates DSS-Induced Colitis and Enhances Gut Homeostasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010561
Vancouver
Jia D, Li Y, Wang Y, Guo Y, Liu J, Zhao S, et al. Probiotic Bacillus licheniformis ZW3 Alleviates DSS-Induced Colitis and Enhances Gut Homeostasis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25010561
BibTeX
@article{Jia2024,
author = {Jia, Dan and Li, Yingying and Wang, Yingjie and Guo, Yanan and Liu, Junlong and Zhao, Shuaiyang and Wang, Jinming and Guan, Guiquan and Luo, Jianxun and Yin, Hong and Tang, Lijie and Li, Youquan},
title = {Probiotic Bacillus licheniformis ZW3 Alleviates DSS-Induced Colitis and Enhances Gut Homeostasis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25010561}
}
EUVIMED